Oct 13, 2020 7:00am EDT Can-Fite to Host Conference Call to Update Shareholders on Positive Interim Results of its Phase III Psoriasis Study on October 15, 2020
Sep 30, 2020 7:00am EDT Can-Fite Selected to Deliver Late-Breaking Oral Presentation on Namodenoson’s Treatment of NASH at American Association for the Study of Liver Diseases Conference
Sep 08, 2020 7:00am EDT Can-Fite to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020
Aug 27, 2020 7:00am EDT Can-Fite Reports Second Quarter 2020 Financial Results & Provides Clinical Update
Aug 26, 2020 7:00am EDT Can-Fite to Present at The LD Micro 500 Virtual Conference on September 1, 2020
Aug 25, 2020 8:09am EDT Can-Fite Receives Notification of Patent Grant from European Patent Office for Namodenoson in the Treatment of NASH
Aug 20, 2020 7:00am EDT Can-Fite to Conduct Investor Call to Review Q2 Results and Provide Business Update on Thursday, August 27, 2020 at 4:15 p.m. ET
